Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

Cited In for PubMed (Select 20157306)

1.

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease.

Paquet C, Dumurgier J, Hugon J.

Front Neurol. 2015 Aug 4;6:168. doi: 10.3389/fneur.2015.00168. eCollection 2015. Review.

2.

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.

Wennström M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, Nielsen HM.

PLoS One. 2015 Aug 13;10(8):e0135458. doi: 10.1371/journal.pone.0135458. eCollection 2015.

3.

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.

Hendrickson RC, Lee AY, Song Q, Liaw A, Wiener M, Paweletz CP, Seeburger JL, Li J, Meng F, Deyanova EG, Mazur MT, Settlage RE, Zhao X, Southwick K, Du Y, Holder D, Sachs JR, Laterza OF, Dallob A, Chappell DL, Snyder K, Modur V, King E, Joachim C, Bondarenko AY, Shearman M, Soper KA, Smith AD, Potter WZ, Koblan KS, Sachs AB, Yates NA.

PLoS One. 2015 Aug 13;10(8):e0135365. doi: 10.1371/journal.pone.0135365. eCollection 2015.

4.

The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.

Bruno D, Grothe MJ, Nierenberg J, Teipel SJ, Zetterberg H, Blennow K, Pomara N.

Alzheimers Dement (Amst). 2015 Mar 1;1(1):81-86.

PMID:
26258161
5.

Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation.

Cicognola C, Chiasserini D, Parnetti L.

Front Neurol. 2015 Jun 29;6:143. doi: 10.3389/fneur.2015.00143. eCollection 2015. Review.

6.

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD.

Schindler SE, Fagan AM.

Front Neurol. 2015 Jun 29;6:142. doi: 10.3389/fneur.2015.00142. eCollection 2015. Review.

7.

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.

Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P.

Alzheimers Res Ther. 2015 Jul 1;7(1):40. doi: 10.1186/s13195-015-0124-3. eCollection 2015.

8.

Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.

Struyfs H, Niemantsverdriet E, Goossens J, Fransen E, Martin JJ, De Deyn PP, Engelborghs S.

Front Neurol. 2015 Jun 17;6:138. doi: 10.3389/fneur.2015.00138. eCollection 2015.

9.

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer's Disease.

Lopez-Font I, Cuchillo-Ibañez I, Sogorb-Esteve A, García-Ayllón MS, Sáez-Valero J.

Front Neurol. 2015 Jun 2;6:125. doi: 10.3389/fneur.2015.00125. eCollection 2015. Review.

10.

Increased cerebrospinal fluid fibrinogen in major depressive disorder.

Hattori K, Ota M, Sasayama D, Yoshida S, Matsumura R, Miyakawa T, Yokota Y, Yamaguchi S, Noda T, Teraishi T, Hori H, Higuchi T, Kohsaka S, Goto Y, Kunugi H.

Sci Rep. 2015 Jun 17;5:11412. doi: 10.1038/srep11412.

11.

Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity.

Macfarlane MD, Jakabek D, Walterfang M, Vestberg S, Velakoulis D, Wilkes FA, Nilsson C, van Westen D, Looi JC, Santillo AF.

PLoS One. 2015 Jun 15;10(6):e0129692. doi: 10.1371/journal.pone.0129692. eCollection 2015.

12.

Body fluid biomarkers in Alzheimer's disease.

Lu H, Zhu XC, Jiang T, Yu JT, Tan L.

Ann Transl Med. 2015 Apr;3(5):70. doi: 10.3978/j.issn.2305-5839.2015.02.13. Review.

13.

Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.

Ossenkoppele R, Mattsson N, Teunissen CE, Barkhof F, Pijnenburg Y, Scheltens P, van der Flier WM, Rabinovici GD.

Neurobiol Aging. 2015 Aug;36(8):2340-7. doi: 10.1016/j.neurobiolaging.2015.04.011. Epub 2015 Apr 25.

14.

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models.

Maia LF, Kaeser SA, Reichwald J, Lambert M, Obermüller U, Schelle J, Odenthal J, Martus P, Staufenbiel M, Jucker M.

EMBO Mol Med. 2015 May 15;7(7):895-903. doi: 10.15252/emmm.201505026.

15.

Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.

Rolstad S, Jakobsson J, Sellgren C, Ekman CJ, Blennow K, Zetterberg H, Pålsson E, Landén M.

PLoS One. 2015 May 8;10(5):e0127100. doi: 10.1371/journal.pone.0127100. eCollection 2015.

16.

Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.

Plagg B, Marksteiner J, Kniewallner KM, Humpel C.

Biogerontology. 2015 Aug;16(4):543-58. doi: 10.1007/s10522-015-9580-1. Epub 2015 May 7.

17.

d-serine levels in Alzheimer's disease: implications for novel biomarker development.

Madeira C, Lourenco MV, Vargas-Lopes C, Suemoto CK, Brandão CO, Reis T, Leite RE, Laks J, Jacob-Filho W, Pasqualucci CA, Grinberg LT, Ferreira ST, Panizzutti R.

Transl Psychiatry. 2015 May 5;5:e561. doi: 10.1038/tp.2015.52.

18.

Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.

Sankaranarayanan S, Barten DM, Vana L, Devidze N, Yang L, Cadelina G, Hoque N, DeCarr L, Keenan S, Lin A, Cao Y, Snyder B, Zhang B, Nitla M, Hirschfeld G, Barrezueta N, Polson C, Wes P, Rangan VS, Cacace A, Albright CF, Meredith J Jr, Trojanowski JQ, Lee VM, Brunden KR, Ahlijanian M.

PLoS One. 2015 May 1;10(5):e0125614. doi: 10.1371/journal.pone.0125614. eCollection 2015.

19.
20.

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.

Song L, Lu SX, Ouyang X, Melchor J, Lee J, Terracina G, Wang X, Hyde L, Hess JF, Parker EM, Zhang L.

Mol Neurodegener. 2015 Mar 26;10:14. doi: 10.1186/s13024-015-0011-1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk